KOCHI: George (name changed), was 55-years-old when he was diagnosed with fatty liver. Since he was a teetotaller, he did not ...

Positive results from the MAESTRO-NASH OUTCOMES study could make resmetirom the first medication approved for patients with compensated NASH ...

As one in three Indians gets diagnosed with non-alcoholic fatty liver, a look at how lifestyle choices can make a difference.

Non-alcoholic fatty liver disease (NAFLD ... drug sensitivity and treatment paradigms for the affected population. Here, Dewald et al. generated liver-specific DM1 mice to demonstrate that ...

An Instagram video has gone viral with the claim that tea made from ginger, turmeric and black pepper can remedy fatty liver ...

June 14, 2024 — Fatty liver disease ... Find an Effective Treatment Jan. 23, 2024 — Metabolic dysfunction--associated steatohepatitis or MASH (formerly known as nonalcoholic steatohepatitis ...

The prevalence rates of metabolic dysfunction–associated steatohepatitis (MASH) and metabolic dysfunction–associated ...

Sagimet is a clinical-stage biopharmaceutical company developing novel fatty acid synthase (FASN) inhibitors that are designed to target dysfunctional metabolic and fibrotic pathways in diseases ...

On October 15, 2024, the list of selected candidates for the oral report of the American Association for the Study of the Liver (AASLD 2024) annual meeting was officially announced online. The ...

Blocking the enzyme ACMSD can significantly reduce damage caused by metabolic liver disease according to a new study.

An investigational oral fatty acid synthase (FASN) inhibitor was associated with significant improvements in metabolic ...

previously known as "non-alcoholic fatty liver disease" - affects about 25% of the global population. Its severe form, ...